Conserved transcriptional regulatory mechanisms in aortic valve development and disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 4, 2014, Pages 737-741

  Wirrig, Elaine E ^a   Yutzey, Katherine E ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Division of Molecular Cardiovascular Biology   (United States)

Author keywords

aortic valve stenosis; bicuspid aortic valve; extracellular matrix; fetal heart; transcription factors

Indexed keywords

ALKALINE PHOSPHATASE; CATHEPSIN K; NOTCH RECEPTOR; NOTCH1 RECEPTOR; OSTEOCALCIN; PROTEOGLYCAN; TENASCIN; TRANSCRIPTION FACTOR GATA 5; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SNAIL; VASCULAR ENDOTHELIAL CADHERIN;

AORTA VALVE DISEASE; ARTICLE; ATRIOVENTRICULAR CANAL; BICUSPID AORTIC VALVE; BLOOD VESSEL CALCIFICATION; CALCIFIC AORTIC VALVE DISEASE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARTILAGE; EMBRYO DEVELOPMENT; ENDOCARDIAL CUSHION; GENE INDUCTION; GENE REGULATORY NETWORK; HEART ATRIOVENTRICULAR VALVE; HEART DEVELOPMENT; HEART VALVE; HUMAN; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; VALVULAR HEART DISEASE;

AORTIC VALVE STENOSIS; BICUSPID AORTIC VALVE; EXTRACELLULAR MATRIX; FETAL HEART; TRANSCRIPTION FACTORS;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART VALVE DISEASES; HUMANS; MORPHOGENESIS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84897050183     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302071     Document Type: Article

References (47)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation. 2011;123:e181-e209.
2. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation. 2006;114:e84-e231.
3. Wirrig EE, Hinton RB, Yutzey KE. Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. J Mol Cell Cardiol. 2011;50:561-569.
4. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcifcation is associated with an osteoblast pheno-type. Circulation. 2003;107:2181-2184.
5. Combs MD, Yutzey KE. Heart valve development: regulatory networks in development and disease. Circ Res. 2009;105:408-421.
6. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-925.
7. Hinton RB Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res. 2006;98:1431-1438.
8. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult. Circulation. 2006;113:1344-1352.
9. Schoen FJ. Evolving concepts of cardiac valve dynamics. Circulation. 2008;118:1864-1880.
10. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. 2011;73:29-46.
11. de Lange FJ, Moorman AF, Anderson RH, Männer J, Soufan AT, de Gier-de Vries C, Schneider MD, Webb S, van den Hoff MJ, Christoffels VM. Lineage and morphogenetic analysis of the cardiac valves. Circ Res. 2004;95:645-654.
12. Lincoln J, Alferi CM, Yutzey KE. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn. 2004;230:239-250.
13. Nakamura T, Colbert MC, Robbins J. Neural crest cells retain multipoten-tial characteristics in the developing valves and label the cardiac conduction system. Circ Res. 2006;98:1547-1554.
14. Wessels A, van den Hoff MJ, Adamo RF, Phelps AL, Lockhart MM, Sauls K, Briggs LE, Norris RA, van Wijk B, Perez-Pomares JM, Dettman RW, Burch JB. Epicardially derived fbroblasts preferentially contribute to the parietal leafets of the atrioventricular valves in the murine heart. Dev Biol. 2012;366:111-124.
15. Visconti RP, Ebihara Y, LaRue AC, Fleming PA, McQuinn TC, Masuya M, Minamiguchi H, Markwald RR, Ogawa M, Drake CJ. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res. 2006;98:690-696.
16. Hajdu Z, Romeo SJ, Fleming PA, Markwald RR, Visconti RP, Drake CJ. Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process. J Mol Cell Cardiol. 2011;51:955-965.
17. Timmerman LA, Grego-Bessa J, Raya A, Bertrán E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick F, Izpisúa-Belmonte JC, de la Pompa JL. Notch promotes epithelial- mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18:99-115.
18. Chakraborty S, Combs MD, Yutzey KE. Transcriptional regulation of heart valve progenitor cells. Pediatr Cardiol. 2010;31:414-421.
19. Shelton EL, Yutzey KE. Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev Biol. 2008;317:282-295.
20. Chakraborty S, Wirrig EE, Hinton RB, Merrill WH, Spicer DB, Yutzey KE. Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves. Dev Biol. 2010;347:167-179.
21. Lee MP, Yutzey KE. Twist1 directly regulates genes that promote cell proliferation and migration in developing heart valves. PLoS One. 2011;6:e29758.
22. Lincoln J, Kist R, Scherer G, Yutzey KE. Sox9 is required for precursor cell expansion and extracellular matrix gene expression. Dev Biol. 2007;302:376-388
23. Shelton EL, Yutzey KE. Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol. 2007;302:376-388.
24. Cai X, Zhang W, Hu J, Zhang L, Sultana N, Wu B, Cai W, Zhou B, Cai CL. Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis. Development. 2013;140:3176-3187.
25. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW. Role of NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 1998;392:182-186.
26. Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 1998;392:186-190.
27. Combs MD, Yutzey KE. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ Res. 2009;105:565-574.
28. Wu B, Wang Y, Lui W, Langworthy M, Tompkins KL, Hatzopoulos AK, Baldwin HS, Zhou B. Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. Circ Res. 2011;109:183-192.
29. Lincoln J, Alferi CM, Yutzey KE. BMP and FGF regulatory pathways control cell lineage diversifcation of heart valve precursor cells. Dev Biol. 2006;292:292-302.
30. Levay AK, Peacock JD, Lu Y, Koch M, Hinton RB Jr, Kadler KE, Lincoln J. Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ Res. 2008;103:948-956.
31. Cripe L, Andelfnger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable. J Am Coll Cardiol. 2004;44:138-143.
32. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270-274.
33. Nus M, MacGrogan D, Martínez-Poveda B, Benito Y, Casanova JC, Fernández-Avilés F, Bermejo J, de la Pompa JL. Diet-induced aortic valve disease in mice haploinsuffcient for the Notch pathway effector RBPJK/CSL. Arterioscler Thromb Vasc Biol. 2011;31:1580-1588.
34. Padang R, Bagnall RD, Richmond DR, Bannon PG, Semsarian C. Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease. J Mol Cell Cardiol. 2012;53:277-281.
35. Laforest B, Andelfnger G, Nemer M. Loss of Gata5 in mice leads to bicuspid aortic valve. J Clin Invest. 2011;121:2876-2887.
36. Hofmann JJ, Briot A, Enciso J, Zovein AC, Ren S, Zhang ZW, Radtke F, Simons M, Wang Y, Iruela-Arispe ML. Endothelial deletion of murine Jag1 leads to valve calcifcation and congenital heart defects associated with Alagille syndrome. Development. 2012;139:4449-4460.
37. Kokubo H, Miyagawa-Tomita S, Nakashima Y, Kume T, Yoshizumi M, Nakanishi T, Saga Y. Hesr2 knockout mice develop aortic valve disease with advancing age. Arterioscler Thromb Vasc Biol. 2013;33:e84-e92.
38. Peacock JD, Levay AK, Gillaspie DB, Tao G, Lincoln J. Reduced sox9 function promotes heart valve calcifcation phenotypes in vivo. Circ Res. 2010;106:712-719.
39. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcifcation by activating paracrine Wnt signals. J Clin Invest. 2005;115:1210-1220.
40. Alexopoulos A, Bravou V, Peroukides S, Kaklamanis L, Varakis J, Alexopoulos D, Papadaki H. Bone regulatory factors NFATc1 and Osterix in human calcifc aortic valves. Int J Cardiol. 2010;139:142-149.
41. Weiss RM, Lund DD, Chu Y, Brooks RM, Zimmerman KA, El Accaoui R, Davis MK, Hajj GP, Zimmerman MB, Heistad DD. Osteoprotegerin inhibits aortic valve calcifcation and preserves valve function in hyper-cholesterolemic mice. PLoS One. 2013;8:e65201.
42. Wirrig EE, Yutzey KE. Developmental pathways in CAVD. In: Aikawa E, ed. Calcifc Aortic Valve Disease. Croatia: InTech; 2013.
43. Balachandran K, Alford PW, Wylie-Sears J, Goss JA, Grosberg A, Bischoff J, Aikawa E, Levine RA, Parker KK. Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve. Proc Natl Acad Sci USA. 2011;108:19943-19948.
44. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM. Calcifc aortic valve disease: not simply a degenerative process. Circulation. 2011;124:1783-1791.
45. Weiss RM, Miller JD, Heistad DD. Fibrocalcifc aortic valve disease: opportunity to understand disease mechanisms using mouse models. Circ Res. 2013;113:209-222.
46. Boström KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res. 2011;109:564-577.
47. Hermans H, Herijgers P, Holvoet P, Verbeken E, Meuris B, Flameng W, Herregods M-C. Statins for calcifc aortic valve stenosis: into oblivion after SALTIRE and SEAS? Curr Probl Cardiol. 2010;35:284-306.